ODDO BHF ASSET MANAGEMENT SAS
Position in ALNY — Alnylam Pharmaceuticals, Inc.
CIK 1686970
PARIS, I0
Position in ALNY
as of Mar 31, 2026
· filed May 18, 2026
Position Value
$10,923,011
-$1,059,376 QoQ
Shares Held
33,013
+9.6% QoQ
Ownership
0.025%
of shares outstanding
% of Portfolio
0.45%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2025
5 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in ALNY Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026ODDO BHF ASSET MANAGEMENT SAS holds $168,140,352 across 13 Biotechnology names. ALNY ranks #6 (6.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | DAWN |
Day One Biopharmaceuticals, Inc.
|
1,550,000 | $33,232,000 | |
| 2 | APLS |
Apellis Pharmaceuticals, Inc.
|
825,000 | $33,189,750 | |
| 3 | ASND |
Ascendis Pharma A/S
|
128,657 | $29,427,715 | |
| 4 | ARGX |
Argenx SE
|
25,009 | $18,262,822 | |
| 5 | ACLX |
Arcellx, Inc.
|
115,000 | $13,204,300 | |
| 6 | ALNY |
Alnylam Pharmaceuticals, Inc.
This page
|
33,013 | $10,923,011 | |
| 7 | FOLD |
AMICUS THERAPEUTICS, INC.
|
681,000 | $9,847,260 | |
| 8 | ABVX |
Abivax S.A.
|
81,496 | $9,074,579 |
All Filings in ALNY
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $10,923,011 | 33,013 | Shares | Sole | 2026-05-18 | |
| 2025-12-31 | $11,982,387 | 30,133 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $17,294,712 | 37,927 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $11,719,674 | 35,940 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $5,352,066 | 19,821 | Shares | Sole | 2025-05-12 | |
| No filing history on record for this holder in this stock. | ||||||